Growth Metrics

Dare Bioscience (DARE) Cash from Investing Activities (2016 - 2025)

Dare Bioscience's Cash from Investing Activities history spans 11 years, with the latest figure at -$206641.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 63.29% year-over-year to -$206641.0; the TTM value through Dec 2025 reached -$385278.0, up 32.77%, while the annual FY2025 figure was -$385278.0, 32.77% up from the prior year.
  • Cash from Investing Activities reached -$206641.0 in Q4 2025 per DARE's latest filing, down from -$174702.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $282325.0 in Q3 2024 to a low of -$607331.0 in Q4 2023.
  • Average Cash from Investing Activities over 5 years is -$111023.1, with a median of -$22099.0 recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: crashed 22418.76% in 2023, then surged 1377.55% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$14524.0 in 2021, then surged by 81.43% to -$2697.0 in 2022, then plummeted by 22418.76% to -$607331.0 in 2023, then rose by 7.32% to -$562849.0 in 2024, then skyrocketed by 63.29% to -$206641.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Cash from Investing Activities are -$206641.0 (Q4 2025), -$174702.0 (Q3 2025), and $153396.0 (Q2 2025).